Quiz 3 Drugs - Folate antagonists, Quinolones, UTI agents Flashcards

1
Q

2 types of folate antagonist drugs

A

Sulfonamides and trimethoprim/pyrimethamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Sulfonamides MOA

A

Inhibit dihydrofolate synthesis (specifically dihydropteroate synthetase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Trimethoprim and pyrimethamine MOA

A

Inhibitors of folate reduction (inhibit dihydrofolate reductase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How do humans obtain folate?

A

Obtain reduced folate in diet
This is an example of selective toxicity for many drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Sulfonamides compete with this for folate synthesis pathway

A

PABA (p-aminobenzoic acid)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Sulfonamides are a ______ inhibitor of nucleic acid synthesis

A

Indirect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Sulfonamides are a _______ inhibitor dihyropteroate synthase which prevents PABA incorporation into folic acid

A

Competitive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Spectrum for sulfonamides

A

Broad spectrum
But resistance severely limits actual clinical spectrum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

4 adverse effects of sulfonamides

A

Crystal formation in urine
Blood problems (esp. with G6P dehydrogenase deficiency)
Hypersensitivity
Kernicterus in infants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Glucose-6-P dehydrogenase deficiency is most commonly seen in people from this descent

A

Mediterranean and African origin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Highest risk of acute hemolysis as a result of sulfonamide use is in patients with this

A

Genetic deficiency in RBC glucose-6-phosphate dehydrogenase (FAVism)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Crystal formation in urine, blood problems, hypersensitivity, and kernicterus in infants are adverse effects of this

A

Sulfonamides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Rare medical emergency affecting skin and mucous membranes that can be triggered by sulfonamides
Fever, malaise, erythema multiforme, ulceration of mucous membranes

A

Stevens-Johnson syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is Stevens-Johnson syndrome?

A

Rare medical emergency affecting skin and mucous membranes that can be triggered by sulfonamides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

2 Adverse effects of trimethoprim and pyrimethamine

A

Skin rashes
Major bone marrow toxicity potential when used chronically but can be reduced with folic acid supplementation (Megaloblastic anemia, Leukopenia, Granulocytopenia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Skin rashes and bone marrow toxicity (megaloblastic anemia, leukopenia, granulocytopenia) are adverse effects to this

A

Trimethoprim and Pyrimethamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Bone marrow toxicity when trimethoprim and pyrimethamine are used chronically can be reduced with this

A

Folic acid supplementation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Optimal ratio for Trimethoprim-Sulfamethoxazole combination therapy
Produce sequential blockage of folate synthesis; super additive drug interaction

A

20 parts Sulfa to 1 part Trimethoprim

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Spectrum of quinolones

A

Broad spectrum (block DNA synthesis and function)
Effective for gram negative rods in UTIs and GI infections, and some gram positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

MOA of quinolones

A

Inhibit topoisomerase II (DNA gyrase) and IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Quinolones inhibition of this is the primary drug target in gram negative bacteria

A

DNA gyrase (topoisomerase II)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Quinolones inhibition of this is the primary drug target in gram positive bacteria

A

Topoisomerase IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Quinolones inhibition of DNA gyrase (topoisomerase II) is the primary drug target for this type of bacteria

A

Gram negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Quinolones inhibition of topoisomerase IV is the primary drug target for this type of bacteria

A

Gram positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Drugs that chelates with some metals (e.g. antacids containing aluminum hydroxide or magnesium hydroxide: Maalox, Mylanta)
Quinolones
26
Quinolones chelates with this
Some metals (e.g. antacids containing aluminum hydroxide or magnesium hydroxide: Maalox, Mylanta)
27
4 Common problems with quinolone use
Nauseua, vomiting, diarrhea Nephrotoxicity Avoid use with antacids 3 C's
28
Quinolones should avoid use with these
Antacids
29
Drug that should avoid use with antacids
Quinolones
30
3 C's of quinolones
Central nervous system (headaches, malaise, depression, psychosis, hallucinations) Cartilage (ruptured tendons, avoid use in pregnancy and children) Cardiac toxicity (QT prolongation)
31
The 3 C's (central, cartilage, cardiac) describe the adverse effects of this drug
quinolones
32
Quinolones black box (3)
Avoid use in myasthenia gravis Discontinue at first sign of tendon inflammation or pain Tendon rupture
33
Tendon most vulnerable to rupture with quinolone use (all tendons are vulnerable)
Achilles tendon
34
Tendon rupture can occur as early as _____ hours following first dose, and last ______ after last dose with quinolones
Early as 48 hours Last months after last dose
35
Primary elimination of quinolones
Tubular secretion Blocked by probenecid resulting in longer durations of serum antibacterial action
36
Tubular secretion of quinolones is blocked by this, resulting in longer durations of serum antibacterial action
Probenecid
37
Tubular secretion of this drug is blocked by probenecid, resulting in longer durations of serum antibacterial action
Quinolones
38
2 antiseptic agents used to treat UTIs
Nitrofurans Methenamine
39
MOA of nitrofurans
Form reactive intermediates that damage nucleic acid Requires bacterial reduction enzymes (nitroreductases) for activation
40
Nitrofurans require these for activation
Bacterial reduction enzymes (nitroreductases)
41
This limits mammalian toxicity of nitrofurans
High biotransformation potential with rapid renal excretion keeps serum levels low
42
Spectrum of nitrofurans
Mainly used as gram negative agent (narrow spectrum), but some important activity in gram positive (extended spectrum)
43
This keeps serum levels of nitrofurans very low
First pass effect
44
5 adverse effects of Nitrofurans
Nausea/vomiting Hypersensitivity Pulmonary reactions (acute pneumonia, interstitial fibrosis) Peripheral neuropathy Hemolytic anemia with RBC G6PD deficiency Avoid use in late pregnancy
45
2 pulmonary reactions with nitrofurans
Acute pneumonia Interstitial fibrosis
46
MOA of methenamine
Prodrug that is converted to formaldehyde in acid pH of 5.5 or less in urine, denaturing proteins and is toxic to most bacteria
47
Methenamine is converted to this in acid pH of 5.5 or less in urine
Formaldehyde
48
Spectrum of methenamine
Broad spectrum Is converted to formaldehyde, which is toxic to most bacteria
49
Bacteria that alkalize urine and disrupt methenamine mechanism
Proteus bacteria
50
Proteus bacteria disrupt methenamine mechanism by doing this
Alkalize urine
51
Methenamine is often combined with this to optimize activity
Urine acidifier mandelic acid
52
2 contraindications of methenamine
Elevated ammonia levels make this contraindicated in hepatic dysfunction patients Mandelic acid form contrainidicated in renal dysfunction patients to avoid acid crystallization
53
Elevated ammonia levels (contraindicated in hepatic dysfunction patients) and mandelic acid form (contraindicated in renal dysfunction patients) are effects of this drug
Methenamine
54
Urinary analgesic that alleviates symptoms of UTIs
Phenazopyridine (Azo)
55
Phenazopyridine (Azo) is a minor metabolite of this
Acetaminophen
56
This drug is a minor metabolite of acetaminophen
Phenazopyridine (Azo)
57
Adverse effects of Phenazopyridine (Azo)
Body fluid discoloration Not to be used in renal failure
58
Drug that inhibits dihydropteroate synthase, preventing PABA incorporation into folic acid
Sulfonamides
59
Blood problems (acute hemolysis in G6PD deficiency), hypersensitivity and Stevens-Johnson syndrome, and kernicterus in infants are adverse effects of this drug
Sulfonamides
60
Drugs that inhibit dihydrofolate reductase
Trimethoprim and Pyrimethamine
61
Skin rashes and bone marrow toxicity (megaloblastic anemia, leukopenia, granulocytopenia) are adverse effects of this
Trimethoprim and Pyrimethamine
62
Drugs that inhibit topoisomerase II (DNA gyrase) and IV
Quinolones
63
Part of quinolones black box indicates use should be avoided in this
Myasthenia gravis
64
Tendon rupture is a characteristic adverse effect / warning of this drug
quinolones
65
Drug that forms reactive intermediates and damages nucleic acids
Nitrofurans
66
Nausea/vomiting, hypersensitivity, pulmonary reactions (acute pneumonia, interstitial fibrosis), peripheral neuropathy, hemolytic anemia with RBC G6PD deficiency, and avoid use in late pregnancy are adverse effects of this
Nitrofurans